Under normal circumstances, unblinding the entire trial prematurely can ONLY be ordered by the DSMB.
This has happened on occasion where efficacy has become obvious, but is highly unlikely to occur in a study like ACLs p3 (even if the efficacy is damn good).
- Forums
- ASX - By Stock
- primary completion date ph. 3 trial
Under normal circumstances, unblinding the entire trial...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable